PLPL (Plandai Biotechnology) Change In Receivables: $0.00 Mil (TTM As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Plandai Biotechnology Change In Receivables?

Plandai Biotechnology PLPL -90.00% Change In Receivables is $0.00 Mil as of Jun. 2023.

Plandai Biotechnology's change in receivables for the quarter that ended in Jun. 2023 was $0.00 Mil. It means Plandai Biotechnology's Accounts Receivable stayed the same from Jun. 2022 to Jun. 2023 .

Plandai Biotechnology's change in receivables for the fiscal year that ended in Jun. 2023 was $0.00 Mil. It means Plandai Biotechnology's Accounts Receivable stayed the same from Jun. 2022 to Jun. 2023 .

Plandai Biotechnology's Accounts Receivable for the quarter that ended in Jun. 2023 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Plandai Biotechnology's liquidation value for the six months ended in Jun. 2023 was $-0.44 Mil.

Plandai Biotechnology  (OTCPK:PLPL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Plandai Biotechnology's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0*91
=

2. In Ben Graham's calculation of liquidation value, Plandai Biotechnology's accounts receivable are only considered to be worth 75% of book value:

Plandai Biotechnology's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0-0.443+0.75 * 0+0.5 * 0
=-0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plandai Biotechnology Change In Receivables Related Terms

Plandai Biotechnology Change In Receivables Historical Data

* Premium members only.

The historical data trend for Plandai Biotechnology's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plandai Biotechnology Change In Receivables Chart

Plandai Biotechnology Annual Data
Trend Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.42 0.38 -0.03 0.00 0.00

Plandai Biotechnology Semi-Annual Data
Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.42 0.38 -0.03 0.00 0.00

Plandai Biotechnology Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0.00 Mil mean?
Plandai Biotechnology (PLPL) has a Change In Receivables of $0.00 Mil as of Jun. 2023. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Plandai Biotechnology and its competitors.
Is Plandai Biotechnology's Change In Receivables too high?
Plandai Biotechnology's current Change In Receivables is $0.00 Mil.
How does Plandai Biotechnology's Change In Receivables compare to CRGH and TCRI?
Plandai Biotechnology's Change In Receivables of $0.00 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Business Services company?
A good Change In Receivables depends on the Business Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Plandai Biotechnology and its competitors. Plandai Biotechnology's current Change In Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plandai Biotechnology stock overvalued right now?
Plandai Biotechnology (PLPL) has a current Change In Receivables of $0.00 Mil. The current Change In Receivables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Plandai Biotechnology (PLPL), the current Change In Receivables is $0.00 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Plandai Biotechnology Business Description

Address Xinyi Road, Sector 5, No. 7, 57th Floor - 1, Xinyi District, Taipei, TWN, 330
Plandai Biotechnology Inc is engaged in catering and catering management operations in Taiwan.